ElevateBio logo

ElevateBio

Cambridge, MA

ElevateBio is an operator of a portfolio of cell and gene therapy companies intended to develop, manufacture, and commercialize life-transforming medicines. The company creates a portfolio through partnerships with the world's innovative scientists and inventors as well as it created a centralized facility that integrates all the elements that translate cell and gene therapy R&D into commercially viable therapies quickly and efficiently, enabling patients to get medical products to treat severe diseases. Vikas Sinha, Mitchell Finer, and David Hallal co-founded ElevateBio in Cambridge, Massachusetts in 2017.

elevate.bio

Company Details

Founded

2021

Employees

Between 200 - 1,000 employees

Raised

$1,246,000,000

Headquarters Location

Cambridge, MA

Public

No

Acquired

No

CEO

David HallalDavid Hallal

Founders

Mitchell Finer
Mitchell Finer
David Hallal
David Hallal
Vikas Sinha
Vikas Sinha

Company Collections

These are collections ElevateBio is a part of. Click on the collection name to view similar companies.

ElevateBio's Investors

ElevateBio's Tech Stack

Current Job Listings

Listing 0 of 16 job openings

    ElevateBio Headquarters Location

    139 Main Street Suite 500, Cambridge, MA 02142

    Total Amount Raised: $1,246,000,000

    ElevateBio's Investors

    ElevateBio Funding Rounds

    • Series D

      $401,000,000

      Series D Investors

      Matrix Capital Management
      Redmile Group
      MPM Capital
      SoftBank Vision Fund
      F2 Ventures
      Woodline Partners
      Invus
      Novo Nordisk
      Fidelity
      Emerson Collective
      Surveyor Capital
      EcoR1 Capital
      Samsara BioCapital
      Vertex Ventures
      EDBI
      ITOCHU
    • Series C

      $525,000,000

      Series C Investors

      Matrix Capital Management
      EcoR1 Capital
      MPM Capital
      SoftBank Vision Fund
      F2 Ventures
      Invus
      Fidelity
      Vertex Ventures
      Redmile Group
      ITOCHU
      Surveyor Capital
      Samsara BioCapital
      Emerson Collective
      EDBI
    • Series B

      $170,000,000

      Series B Investors

      EDBI
      Samsara BioCapital
      Invus
      F2 Ventures
      Redmile Group
      MPM Capital
      EcoR1 Capital
      Vertex Ventures
      Surveyor Capital
    • Series A

      $150,000,000

      Series A Investors

      UBS Oncology Impact Fund
      Redmile Group
      Samsara BioCapital
      EcoR1 Capital
    Funding info provided by Diffbot.

    ElevateBio Reviews

    0 out of 5 stars

    Based on 0 reviews

    Review data

    Share your thoughts

    Worked here? Share your experience. Help others decide if this company is right for them. Write a review on ElevateBio.

    Recent reviews